Device Trial Radar · NCT05785949
Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair
Last checked: Nov 20, 2026Latest source record: Mar 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
75
Actual
Start
Mar 10, 2023
Primary completion
Dec 4, 2025
Study completion Jan 31, 2026
Sponsor
- Lead sponsor
- Geistlich Pharma AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- TigerMed
- First posted
- Mar 27, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, multicenter, randomized, parallel controlled study evaluating the safety and efficacy of Chondro-Gide® bilayer collagen membrane in knee cartilage defect repair. The objective of this clinical trial is to evaluate the efficacy and safety of Chondro-Gide® bilayer collagen membrane in knee cartilage defect repair
Conditions
- Cartilage Defects
Interventions
MicrofractureProcedure
Use of standard tool kit to drill vertically from the periphery to the center with a hole spacing of 3\~4 mm with care to prevent penetrating adjacent holes. The hole depth should be 3\~5 mm and fat droplets or blood oozing is seen after loosening the tourniquet. However, no blood oozing is observed in some holes and in such case, the hole depth should be deepened to 5\~7 mm.
Chondro-Gide bilayer collagen membraneDevice
After the Microfracture, the porous layer of the bilayer collagen membrane faces the bone surface. The already trimmed, cut and wetted membrane is insert into the defect and fixed symmetrically with absorbable surgical suture with needle. Knots are put on the pinhole of collagen membrane to avoid tearing of surrounding cartilage or collagen membrane during knotting.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART)Time frame: 24 months postoperative
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Sino-Japanese Friendship Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
The Second Hospital of Jilin University
Changchun, China
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.